Filing Details
- Accession Number:
- 0001123292-19-000751
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-13 19:32:49
- Reporting Period:
- 2019-05-13
- Accepted Time:
- 2019-05-13 19:32:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1661059 | Nextcure Inc. | NXTC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1609405 | Quang Chau Khuong | C/O Nextcure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville MD 20705 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-13 | 445,866 | $0.00 | 445,866 | No | 4 | C | Indirect | By OrbiMed Private Investments VI, LP |
| Common Stock | Acquisiton | 2019-05-13 | 743,110 | $0.00 | 1,188,976 | No | 4 | C | Indirect | By OrbiMed Private Investments VI, LP |
| Common Stock | Acquisiton | 2019-05-13 | 729,599 | $0.00 | 1,918,575 | No | 4 | C | Indirect | By OrbiMed Private Investments VI, LP |
| Common Stock | Acquisiton | 2019-05-13 | 442,438 | $0.00 | 2,361,013 | No | 4 | C | Indirect | By OrbiMed Private Investments VI, LP |
| Common Stock | Acquisiton | 2019-05-13 | 350,000 | $15.00 | 2,711,013 | No | 4 | P | Indirect | By OrbiMed Private Investments VI, LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | By OrbiMed Private Investments VI, LP |
| No | 4 | C | Indirect | By OrbiMed Private Investments VI, LP |
| No | 4 | C | Indirect | By OrbiMed Private Investments VI, LP |
| No | 4 | C | Indirect | By OrbiMed Private Investments VI, LP |
| No | 4 | P | Indirect | By OrbiMed Private Investments VI, LP |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A-1 Preferred Stock | Disposition | 2019-05-13 | 3,582,000 | $0.00 | 445,866 | $0.00 |
| Common Stock | Series A-2 Preferred Stock | Disposition | 2019-05-13 | 5,970,000 | $0.00 | 743,110 | $0.00 |
| Common Stock | Series A-3 Preferred Stock | Disposition | 2019-05-13 | 5,861,455 | $0.00 | 729,599 | $0.00 |
| Common Stock | Series B-1 Preferred Stock | Disposition | 2019-05-13 | 3,554,466 | $0.00 | 442,438 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect | ||
| 0 | No | 4 | C | Indirect |
Footnotes
- The reported securities automatically converted into shares of Common Stock on a 1-for-8.0338 basis upon the closing of the Issuer's initial public offering and had no expiration date.
- OrbiMed Capital GP VI LLC ("GP VI") is the sole general partner of OrbiMed Private Investments VI, LP ("OPI VI"). OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of GP VI. By virtue of such relationships, GP VI and OrbiMed Advisors may be deemed to have voting and investment power with respect to the shares held by OPI VI and as a result may be deemed to have beneficial ownership of such shares. The Reporting Person is an employee of OrbiMed Advisors. OrbiMed Advisors exercises investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho and Jonathan T. Silverstein. Each of GP VI, OrbiMed Advisors and the Reporting Person disclaims beneficial ownership of the shares held by OPI VI, except to the extent of its or his pecuniary interest therein, if any.
Billionaire Hedge Funds
